<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&amp;id=15839069</title><link>https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&amp;id=15839069</link><description>Individual feed output.</description><lastBuildDate>Wed, 29 Jan 2025 07:57:13 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Moderna gets a downgrade from Goldman Sachs on vaccine revenue struggles</title><link>https://www.cnbc.com/2025/01/29/moderna-gets-a-downgrade-from-goldman-sachs-on-vaccine-revenue-struggles.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Analyst Salveen Richter downgraded shares of the biotech company from neutral to buy and significantly lowered her price target.</description><pubDate>Wed, 29 Jan 2025 12:25:50 GMT</pubDate></item><item><title>MicroStrategy is a buy that can gain more than 50% from here, Mizuho says</title><link>https://www.cnbc.com/2025/01/29/microstrategy-is-a-buy-that-can-gain-more-than-50percent-from-here-mizuho-says.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>The firm initiated the stock with an outperform rating and $515 price target.</description><pubDate>Wed, 29 Jan 2025 11:13:51 GMT</pubDate></item><item><title>Wednesday’s big stock stories: What’s likely to move the market in the next trading session</title><link>https://www.cnbc.com/2025/01/28/wednesdays-big-stock-stories-whats-likely-to-move-the-market.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>The S&amp;P 500 and the Nasdaq Composite rose on Tuesday as investors snapped up tech shares. Here's what's on CNBC's radar going into Wednesday.</description><pubDate>Wed, 29 Jan 2025 00:48:27 GMT</pubDate></item><item><title>There’s still value for Nvidia despite DeepSeek threat, says strategist Jay Woods</title><link>https://www.cnbc.com/2025/01/28/theres-still-value-for-nvidia-despite-deepseek-threat-says-strategist-jay-woods.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>Jay Woods of Freedom Capital Markets joined CNBC's "Power Lunch" on Tuesday to offer his take on three key market movers.</description><pubDate>Tue, 28 Jan 2025 21:52:25 GMT</pubDate></item><item><title>Wall Street analysts universally say buy the dip in anything affected by the DeepSeek sell-off</title><link>https://www.cnbc.com/2025/01/28/wall-street-analysts-universally-say-buy-the-dip-in-anything-impacted-by-the-deepseek-sell-off.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Sell-side analysts at major banks are still optimistic on Nvidia and other stocks that fell sharply on Monday.</description><pubDate>Tue, 28 Jan 2025 20:51:05 GMT</pubDate></item></channel></rss>